Gevo, Inc. (Nasdaq: GEVO) 37.5% LOWER; announced today that it intends to offer and sell, subject to market and other conditions, common stock units. Each common stock unit will consist of one share of common stock, Series A warrants to purchase a certain number of shares of common stock and Series B warrants to purchase a certain number of shares of common stock. The units are to be sold by Gevo subject to market and other conditions in an underwritten public offering.
Core Labs (NYSE: CLB) 13.9% LOWER; reported Q4 EPS of